Benzinga | Jun 14, 2021 06:24AM EDT

HC Wainwright & Co. Maintains Buy on Phio Pharmaceuticals, Raises Price Target to $6

HC Wainwright & Co. analyst Vernon Bernardino maintains Phio Pharmaceuticals (NASDAQ:PHIO) with a Buy and raises the price target from $4 to $6.